RE: General3 Feb 2021 22:01
Hi Reflex, Willibo
I researched iqai a wile ago and moved around between iqai and rms, most of my pf is in rms now.
My initial entry point for iqai was 6p. subsequent to this they have fda approval possibly of 2 products and have linked up with an influential clinic in the usa The big validation coming up is cad free scanning. On the face of it the sp should be in my view at least mid 20's.
Something or someone is holding it back.
Personally I think it needs an injection of cash to see it through a year. during this year all its products can start to generate revenue .
My theory is that TB has designs on either a placing or a cln. Either way the cheap shares for this will be around 5 to 6p.
The problem is that if TB is in someway controlling the sp to get the sp he wants to justify the cheap shares, once the (lets say placing) is agreed by the bod there may be a slight downward reaction to the sp but overall the sp may well react the other way.
I hope that the sp will stay at this level so I can buy in . Ok the sp may drop but i think there are lots of people on the sidelines that are very interested it.
For me I am holding rms but when this comes good I will take some profit and put it into iqai.
The other thing which is very attractive about iqai is that potentially it is a takeover target, either way I think it is a win win.